Because of the low specificity of the PSA level in the detection of prostate cancer, patients suspected of having this disease using PSA screening usually receive an unnecessary biopsy; this is an invasive procedure with accompanying complications [15]. This evidence concerns the gene KLK3 and prostate carcinoma.